Ul-Haq Z - Search Results

1

Synthesis, biological evaluation, and molecular docking studies of benzyl, alkyl and glycosyl [2-(arylamino)-4,4-dimethyl-6-oxo-cyclohex-1-ene]carbodithioates, as potential immunomodulatory and immunosuppressive agents.

El Ashry el SH, Amer MR, Abdalla OM, Aly AA, Soomro S, Jabeen A, Halim SA, Ahmed Mesaik M, Ul-Haq Z. El Ashry el SH, et al. Bioorg Med Chem. 2012 May 1;20(9):3000-8. doi: 10.1016/j.bmc.2012.03.003. Epub 2012 Mar 15. Bioorg Med Chem. 2012. PMID: 22480848

2

In silico studies of urease inhibitors to explore ligand-enzyme interactions.

Ansari FL, Wadood A, Ullah A, Iftikhar F, Ul-Haq Z. Ansari FL, et al. J Enzyme Inhib Med Chem. 2009 Feb;24(1):151-6. doi: 10.1080/14756360801945598. J Enzyme Inhib Med Chem. 2009. PMID: 18608771 Free article.

3

Molecular dynamics simulation of Axillaridine-A: a potent natural cholinesterase inhibitor.

ul-Haq Z, Hadi H, Moin ST, Choudhary MI. ul-Haq Z, et al. J Enzyme Inhib Med Chem. 2009 Oct;24(5):1101-5. doi: 10.1080/14756360802632781. J Enzyme Inhib Med Chem. 2009. PMID: 19555175 Free article.

4

Synthesis and biological activity of oxadiazole and triazolothiadiazole derivatives as tyrosinase inhibitors.

Lam KW, Syahida A, Ul-Haq Z, Abdul Rahman MB, Lajis NH. Lam KW, et al. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3755-9. doi: 10.1016/j.bmcl.2010.04.067. Epub 2010 Apr 18. Bioorg Med Chem Lett. 2010. PMID: 20493688 Free article.

5

Immunosuppressive activity of buxidin and E-buxenone from Buxus hyrcana.

Mesaik MA, Halim SA, Ul-Haq Z, Choudhary MI, Shahnaz S, Ayatollahi SA, Murad S, Ahmad A. Mesaik MA, et al. Chem Biol Drug Des. 2010 Mar;75(3):310-7. doi: 10.1111/j.1747-0285.2009.00906.x. Epub 2010 Jan 19. Chem Biol Drug Des. 2010. PMID: 20659112

6

In silico and in vitro immunomodulatory studies on compounds of Lindelofia stylosa.

Mesaik MA, Jabeen A, Halim SA, Begum A, Khalid AS, Asif M, Fatima B, Ul-Haq Z, Choudhary MI. Mesaik MA, et al. Chem Biol Drug Des. 2012 Mar;79(3):290-9. doi: 10.1111/j.1747-0285.2011.01310.x. Chem Biol Drug Des. 2012. PMID: 22181857

7

A combined 3D-QSAR and molecular docking strategy to understand the binding mechanism of (V600E)B-RAF inhibitors.

Ul-Haq Z, Mahmood U, Reza S. Ul-Haq Z, et al. Mol Divers. 2012 Nov;16(4):771-85. doi: 10.1007/s11030-012-9395-9. Epub 2012 Oct 4. Mol Divers. 2012. PMID: 23054531

8

Identification of novel Interleukin-2 inhibitors through computational approaches.

Halim SA, Abdalla OM, Mesaik MA, Wadood A, ul-Haq Z, Kontoyianni M. Halim SA, et al. Mol Divers. 2013 May;17(2):345-55. doi: 10.1007/s11030-013-9431-4. Epub 2013 Mar 14. Mol Divers. 2013. PMID: 23494734

9

A combined 3D-QSAR and docking studies for the In-silico prediction of HIV-protease inhibitors.

Ul-Haq Z, Usmani S, Shamshad H, Mahmood U, Halim SA. Ul-Haq Z, et al. Chem Cent J. 2013 May 17;7(1):88. doi: 10.1186/1752-153X-7-88. Chem Cent J. 2013. PMID: 23683267 Free PMC article.

10

In-vitro immunomodulatory and anti-cancerous activities of biotransformed products of Dianabol through Azadirachta indica and its molecular docking studies.

Saifullah, Khan S, Azizuddin, Halim SA, Kashif M, Jabeen A, Asif M, Mesaik MA, Ul-Haq Z, Dar A, Choudhary MI. Saifullah, et al. Chem Cent J. 2013 Oct 7;7:163. doi: 10.1186/1752-153X-7-163. eCollection 2013. Chem Cent J. 2013. PMID: 24764465 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters